p63 and p73 expression in extrahepatic bile duct carcinoma and their clinical significance

Journal of Molecular Histology

Volumn 38, Issue 3, 2007, Pages 167-175

  Hong, Seung Mo ^a   Cho, HyungJun ^b   Moskaluk, Christopher A ^c   Yu, Eunsil ^d   Zaika, Alexander I ^e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Korea University   (South Korea)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d University of Ulsan College of Medicine   (South Korea)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clolangiocarcinoma; Extrahepatic bile duct; p63; p73

Indexed keywords

PROTEIN P63; PROTEIN P73;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER INVASION; CANCER LOCALIZATION; EXTRAHEPATIC BILE DUCT OBSTRUCTION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; SURVIVAL RATE; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS;

EID: 34250842813     PISSN: 15672379     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10735-007-9084-7     Document Type: Article

References (28)

1. Barbieri CE, Pietenpol JA (2006) p63 and epithelial biology. Exp Cell Res 312:695-706
2. Carriaga MT, Henson DE (1995) Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 75:171-190
3. Cho NH, Kim YB, Park TK, Kim GE, Park K, Song KJ (2003) P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma. Gynecol Oncol 91:346-353
4. Choi HR, Batsakis JG, Zhan F, Sturgis E, Luna MA, El-Naggar AK (2002) Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum Pathol 33:158-164
5. Della Torre G, Pasquini G, Pilotti S, Alasio L, Civelli E, Cozzi G, Milella M, Salvetti M, Pierotti MA, Severini A (2000) TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas. Diagn Mol Pathol 9:41-46
6. Green FL, Page DL, Haller DG, Flemming ID, Morrow M, Fritz A (2002) AJCC cancer staging manual, 6th edn. Springer-Verlag, Berlin Heidelberg New York
7. Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, Ratovitski EA, Jen J, Sidransky D (2000) AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 97:5462-5467
8. Ichimiya S, Kojima T, Momota H, Kondo N, Ozaki T, Nakagawara A, Toribio ML, Imamura M, Sato N (2002) p73 is expressed in human thymic epithelial cells. J Histochem Cytochem 50:455-462
9. Jarnagin WR, Koea JB, Klimstra DS (2002) Cancers of the biliary tree: staging, technique, and pathology. In: Dally JM, Kelson DP, Levin B, Kern SE, Tepper JE (eds) Gastrointestinal oncology: Principles and practice. Lippincott Williams & Wilkins, Philadelphia, pp 615-643
10. Jonas S, Springmeier G, Tauber R, Wiedenmann B, Lobeck H, Gessner R., Kreft B, Kling N, Moelling K, Neuhaus P (1998) p53 mutagenesis in Klatskin tumors. Hum Pathol 29:955-960
11. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X et al. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819
12. Liu L, Cui X, Sakaguchi T, Sasaki M, Suda T, Hatakeyama K (2001) Expression of p73 in colorectal carcinoma: clinicopathological relevance. J Int Med Res 29:297-303
13. Lo Muzio L, Santarelli A, Caltabiano R, Rubini C, Pieramici T, Trevisiol L, Carinci F, Leonardi R, De Lillo A, Lanzafame S et al. (2005) p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Hum Pathol 36:187-194
14. Momoi H, Okabe H, Kamikawa T, Satoh S, Ikai I, Yamamoto M, Nakagawara A, Shimahara Y, Yamaoka Y, Fukumoto M (2001) Comprehensive allelotyping of human intrahepatic cholangiocarcinoma. Clin Cancer Res 7:2648-2655
15. Niyazi M, Ghazizadeh M, Konishi H, Kawanami O, Sugisaki Y, Araki T (2003) Expression of p73 and c-Abl proteins in human ovarian carcinomas. J Nippon Med Sch 70:234-242
16. Nomoto K, Tsuneyama K, Cheng C, Takahashi H, Hori R, Murai Y, Takano Y (2006) Intrahepatic cholangiocarcinoma arising in cirrhotic liver frequently expressed p63-positive basal/stem-cell phenotype. Pathol Res Pract 202:71-76
17. Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW (2006) p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9:45-56
18. Sun XF (2002) p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma. Clin Cancer Res 8:165-170
19. Suto T, Habano W, Sugai T, Uesugi N, Funato O, Kanno S, Saito K, Nakamura S (2000) Aberrations of the K-ras, p53, and APC genes in extrahepatic bile duct cancer. J Surg Oncol 73:158-163
20. Swierczynski SL, Maitra A, Abraham SC, Iacobuzio-Donahue CA, Ashfaq R, Cameron JL, Schulick RD, Yeo CJ, Rahman A, Hinkle DA et al. (2004) Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol 35:357-366
21. Tannapfel A, Engeland K, Weinans L, Katalinic A, Hauss J, Mossner J, Wittekind C (1999a) Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver. Br J Cancer 80:1069-1074
22. Tannapfel A, Wasner M, Krause K, Geissler F, Katalinic A, Hauss J, Mossner J, Engeland K, Wittekind C (1999b) Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst 91:1154-1158
23. Tomkova K, Belkhiri A, El-Rifai W, Zaika AI (2004) p73 isoforms can induce T-cell factor-dependent transcription in gastrointestinal cells. Cancer Res 64:6390-6393
24. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307-310
25. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305-316
26. Yang B, House MG, Guo M, Herman JG, Clark DP (2005) Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma. Mod Pathol 18:412-420
27. Zaika AI, El-Rifai W (2006) The role of p53 protein family in gastrointestinal malignancies. Cell Death Differ 13:935-940
28. Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, Chalas E, Moll UM (2002) DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 196:765-780